Skip to main content
. 2023 Oct 16;6(1):100931. doi: 10.1016/j.jhepr.2023.100931

Fig. 3.

Fig. 3

Variation in the prescription of second-line treatment in England and Scotland.

Funnel plot displaying the number of patients with inadequate response receiving second-line treatment according to the number of patients with inadequate UDCA response seen by each centre in England and Scotland. ∗Teaching hospital affiliated to a medical school. ∗∗District general hospital. SLT, second-line therapy; UDCA, ursodeoxycholic acid.